Mersana Therapeutics Inc UPLIFT Data Update Call Transcript
Good day, and welcome to the Mersana Therapeutics Conference Call. (Operator Instructions) Please note that today's event is being recorded.
At this time, I would like to turn the call over to Mersana's Senior Vice President of Investor Relations and Corporate Communications, Jason Fredette. Please go ahead.
Thank you, operator, and good morning, everyone.
Before we begin, please note that this call will contain forward-looking statements within the meaning of federal securities laws. These statements may include, but are not limited to, those related to the therapeutic potential of our product candidates and our platforms, business strategy, clinical trial execution, regulatory engagements, plans and objectives, business development efforts, cost, operating expenses, cost reduction efforts and cash runway.
Each of these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |